Insights · Articles
Articles.
Educational and editorial pieces on transduction biology, manufacturing economics, and process design — for researchers, process teams, and cell therapy innovators.
Article
HiTE™ vs. Conventional Viral Transduction Enhancers: Efficiency, Safety, and Manufacturing Impact
Compare HiTE™ with retronectin, Polybrene, and LentiBOOST across efficiency, viability, VCN, and workflow impact in T cells, NK cells, and iPSCs.
Read article →Article
NK Cell Lentiviral Transduction: Why It's Hard and How HiTE™ Helps
The biology that makes primary NK cells notoriously difficult to transduce, and how a TFP-based approach reshapes the math for CAR-NK programs.
Read article →Article
How Better Transduction Reduces CAR-T Manufacturing Cost and Risk
Where transduction sits in CAR-T COGS, how vector consumption and yield variability drive cost, and what high-efficiency enhancement means for late-stage programs.
Read article →